Sourcing high-purity KPV tripeptide requires stringent analytical verification and absolute lot traceability. PX1 Research supplies USA-manufactured, laboratory-grade reference compounds backed by comprehensive RP-HPLC and mass spectrometry testing for advanced preclinical protocols.
Sourcing high-purity KPV tripeptide requires stringent analytical verification and absolute lot traceability. PX1 Research supplies USA-manufactured, laboratory-grade reference compounds backed by comprehensive RP-HPLC and mass spectrometry testing for advanced preclinical protocols.
To buy KPV peptide for research protocols, investigators require analytical grade material with verified sequence purity and batch consistency. KPV (Lysine-Proline-Valine) is a C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH) evaluated in preclinical models for its ability to modulate intracellular inflammatory cascades without activating melanocortin receptors.
When acquiring research compounds, laboratories must ensure the material is strictly verified via reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS). PX1 Research provides research-grade KPV synthesized in ISO 17025 accredited, GMP-compliant facilities in the United States, complete with lot-specific documentation for qualified academic and industrial institutions. Explore our complete catalog of research peptides to review current analytical standards.
KPV is a tripeptide consisting of the amino acid sequence L-Lysine–L-Proline–L-Valine (H-Lys-Pro-Val-OH). Derived from the carboxyl-terminal region of alpha-MSH, KPV retains the core anti-inflammatory sequence motif of the parent hormone while lacking the amino acid residues responsible for binding to classic melanocortin receptors (MC1R through MC5R).
Because it lacks receptor-binding affinity for MC1R, KPV does not induce melanogenesis or pigmentary changes in experimental models. Its molecular weight of approximately 341.45 g/mol makes it significantly smaller than parent neuropeptides, facilitating unique cellular transport characteristics across epithelial membranes during in vitro and ex vivo tissue assays.
The primary mechanism observed in preclinical evaluations of KPV centers on the suppression of nuclear factor kappa B (NF-κB) nuclear translocation. In vitro cellular assays demonstrate that KPV enters the cytoplasm via PepT1 (peptide transporter 1), an influx transporter expressed abundantly in intestinal epithelial cells and macrophages.
Once internalized, KPV inhibits the phosphorylation and degradation of IκB-α, thereby preventing the p65 subunit of NF-κB from translocating to the nucleus. Preclinical data indicate that this nuclear blockade reduces the transcriptional activation of pro-inflammatory cytokines, including TNF-α, IL-1β, IL-6, and IL-8, under lipopolysaccharide (LPS)-induced inflammatory conditions.
Additional molecular research documented in our peptide research hub highlights how KPV may interact directly with importin proteins to disrupt the nuclear import mechanism required for inflammatory gene expression.
In animal models of inflammatory bowel disease (IBD), including dextran sulfate sodium (DSS)-induced and trinitrobenzene sulfonic acid (TNBS)-induced colitis in rodents, KPV administration demonstrated measurable reductions in histological inflammation scores and mucosal erosion.
Rodent studies show that KPV treatment preserves mucosal architecture by upregulating key tight junction proteins, specifically Zonula Occludens-1 (ZO-1) and Occludin. By maintaining tight junction complex assembly, the tripeptide helps reduce epithelial permeability and bacterial translocation across the mucosal membrane.
Furthermore, comparative assays using nanoparticle-encapsulated KPV show target-specific localization within inflamed intestinal tissues, resulting in decreased myeloperoxidase (MPO) activity and reduced neutrophil infiltration in target tissues.
In addition to cytokine suppression, in vitro studies indicate that KPV exhibits direct antimicrobial and antifungal properties. Antimicrobial assays using *Candida albicans* and *Staphylococcus aureus* cultures show that KPV disrupts microbial cell membranes and inhibits germination at micromolar concentrations.
The dual mechanism of action—combining anti-inflammatory pathway inhibition with direct microbial growth suppression—makes KPV a critical focus in mucosal immunology research. Researchers studying epithelial defense systems often evaluate KPV alongside antimicrobial peptides like LL-37 to map broad-spectrum cellular response networks.
In gastrointestinal and tissue repair models, KPV is frequently evaluated alongside other prominent research compounds. While KPV primarily targets PepT1-mediated NF-κB suppression, BPC-157 acts through VEGFR2 activation and nitric oxide pathway modulation, and Larazotide functions directly as a tight junction receptor antagonist.
Understanding these distinct pathways allows investigators to design comprehensive multi-compound in vitro studies targeting distinct facets of mucosal repair, cytokine regulation, and cellular junction stability. Laboratories seeking bulk quantities for multi-target screening programs can consult our wholesale lab portal for specialized volume arrangements.
When purchasing compounds for quantitative laboratory assays, analytical purity is non-negotiable. Substandard peptides containing truncated sequences, residual counter-ions, or bacterial endotoxins yield erratic cellular responses and unreplicable experimental results.
PX1 Research enforces strict quality assurance protocols for every lot of KPV 5mg. Every batch undergoes dual-stage verification:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm structural purity exceeding 98.0%. 2. Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise monoisotopic mass and sequence identity. 3. Bacterial Endotoxin (LAL) Testing ensuring limits below 0.01 EU/μg to prevent false-positive immune activation in cell culture assays.
All analytical testing is performed by independent ISO 17025 accredited laboratories within the USA, with lot-specific Certificates of Analysis (COAs) accessible directly to verified researchers.
KPV is supplied as a lyophilized (freeze-dried) powder in sealed, sterile glass vials to ensure long-term physical and chemical stability. To preserve peptide integrity prior to assay preparation, research facilities should adhere to standardized handling protocols:
Lyophilized KPV should be stored at -20°C upon receipt for short-to-medium term storage, or at -80°C for extended archival preservation. Vials should be allowed to equilibrate to room temperature inside a desiccator before opening to prevent atmospheric moisture condensation on the cake.
For reconstitution, sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) should be introduced gently down the inner glass wall of the vial. Gently swirl the vial until complete dissolution occurs; do not vortex vigorously, as shear stress can induce mechanical degradation of peptide bonds. Reconstituted aliquots should be frozen at -20°C or -80°C to avoid repeated freeze-thaw cycles.
Navigating the research peptide supply chain requires stringent criteria to filter out non-compliant vendors. Qualified research institutions should prioritize domestic suppliers that fulfill the following quality baseline:
First, verify that synthesis and packaging occur in GMP-compliant, USA-based facilities subject to strict environmental controls. Second, insist on lot-traceable COAs displaying raw HPLC chromatograms and mass spectra rather than generic text certificates. Third, ensure the supplier explicitly manufactures compounds strictly for in vitro and preclinical laboratory research, upholding regulatory compliance and scientific integrity.
PX1 Research ships all orders directly from state-of-the-art dispatch centers in California and Arizona, offering same-day dispatch for orders finalized prior to cutoff times to support fast-moving scientific timelines.
What is the primary function of KPV in preclinical research?
KPV is primarily researched for its ability to inhibit NF-κB activation, downregulate pro-inflammatory cytokine expression, and preserve epithelial tight junction integrity in cellular and animal models of intestinal inflammation.
How does KPV enter target cells during in vitro experiments?
Preclinical studies show that KPV is actively transported across cell membranes, particularly in intestinal epithelial cells and macrophages, via the solute carrier transporter PepT1 (peptide transporter 1).
Does KPV cause skin pigmentation like full-length alpha-MSH?
No. KPV consists of the C-terminal tripeptide of alpha-MSH and lacks the amino acid sequence required to bind and activate melanocortin receptors (such as MC1R) responsible for melanogenesis.
What analytical methods are used to verify PX1 Research KPV?
Every lot of KPV from PX1 Research is analyzed via RP-HPLC to confirm >98% purity, ESI-MS to confirm molecular mass, and LAL assays to ensure endotoxin levels remain below 0.01 EU/μg.
What solvent should be used to reconstitute KPV for laboratory use?
KPV readily dissolves in sterile research-grade water, bacteriostatic water, or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the specific cell culture or assay buffer system.
How should reconstituted KPV solutions be stored?
Once reconstituted, KPV aliquots should be stored at -20°C or -80°C to prevent enzymatic breakdown and chemical degradation. Avoid repeated freeze-thaw cycles by preparing single-use experimental volumes.
Where are PX1 Research peptides manufactured and shipped from?
PX1 Research compounds are manufactured in USA-based, ISO 17025 accredited and GMP-compliant facilities. Orders ship directly from fulfillment centers in California and Arizona.
Can KPV be ordered in bulk for large-scale laboratory screening?
Yes. Institutional buyers and research facilities requiring bulk quantities or custom vial sizing can establish institutional accounts through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.